CLOCK and leukemia: A comprehensive understanding of how circadian genes behave in leukemia will not only provide insights into how the molecular clock is impacted in this disease but such an understanding could also be used to develop treatment strategies whereby drugs are administered to patients in leukemia in synchrony with their molecular clocks to facilitate greater effectiveness of drug administration to the patients (a process known as chronotherapy).